Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)

NCT04467489 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04467489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04467489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Active, not recruiting
Start date
May 22, 2020
Completion date
June 30, 2026
Enrollment
1,040 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cavernous angioma, cerebral cavernous malformation, hemorrhagic microangiopathy